We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$824M
AUM Growth
+$36.1M
Cap. Flow
+$24.8M
Cap. Flow %
3.01%
Top 10 Hldgs %
72.89%
Holding
30
New
2
Increased
8
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
AGEN
Agenus
AGEN
+$17.5M
2
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$17.2M
3
PGEN icon
Precigen
PGEN
+$6.73M
4
CFRX
ContraFect Corporation
CFRX
+$5.99M
5
MZOR
Mazor Robotics Ltd.
MZOR
+$3.09M

Top Sells

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$7.37M
2
RGLS
Regulus Therapeutics
RGLS
+$7.33M
3
ABEO icon
Abeona Therapeutics
ABEO
+$4.24M
4
TSRO
TESARO, Inc.
TSRO
+$3.64M
5
NXTM
NxStage Medical Inc.
NXTM
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 75.91%
2 Consumer Staples 0.52%
3 Financials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTS
26
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$210K 0.03%
60,000
-51,789
-46% -$183K
ABEO icon
27
Abeona Therapeutics
ABEO
$364M
– –
-53,958
Closed -$4.24M
CERS icon
28
Cerus
CERS
$433M
– –
-659,900
Closed -$2.75M
MNTA
29
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-147,895
Closed -$2.25M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Oracle Investment Management held 30 positions worth $824M, up 4.6% from $788M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Oracle Investment Management deployed $24.8M of net new capital in Q2 2015, opening 2 new positions and adding to 8 existing holdings. Its largest new stake was ContraFect Corporation: 1,478 shares worth $6.21M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Acorda Therapeutics, an estimated $7.37M trimmed.

  • Oracle Investment Management's largest Q2 2015 buy was ContraFect Corporation: 1,478 shares worth $6.21M.
  • Oracle Investment Management added most to Agenus in Q2 2015, an estimated $17.5M increase.
  • Oracle Investment Management's biggest Q2 2015 reduction was Acorda Therapeutics, cutting an estimated $7.37M.
  • Oracle Investment Management fully exited Abeona Therapeutics in Q2 2015, selling an estimated $4.24M.
  • Oracle Investment Management's ten largest holdings make up 73% of its $824M portfolio in Q2 2015.
  • Oracle Investment Management opened 2 new positions and closed 3 in Q2 2015.
  • Oracle Investment Management's portfolio value rose 4.6% quarter-over-quarter to $824M.

Based on Oracle Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.